Clinical Trials | Romosozumab as an Adjunct to Physiologic Estrogen Replacement in Adolescents and Young Adults with Functional Hypothalamic Amenorrhea
Romosozumab as an Adjunct to Physiologic Estrogen Replacement in Adolescents and Young Adults with Functional Hypothalamic Amenorrhea
The Department of Pediatrics seeks young women, ages 14-30 years, having fewer than 3 menstrual periods in the last 6 months, and therefore at risk for low bone density. This 12-month-long study involves 9 study visits at the University of Virginia's main campus, which will include history & physical exams, blood draws, questionnaires about your exercise and eating habits, and bone density scans. We will assess for a bone age at least 14 years old and a BMD Z-score = -1.0 at = 1 skeletal site in order to proceed with study. Participants will be compensated up to $1550 for completing all study visits, and there is no cost to them as all study-related investigations are covered. The data we collect may be used to improve care and resources for future patients. For more information, please contact the study team at [email protected], or 434-982-4049.